trending Market Intelligence /marketintelligence/en/news-insights/trending/s0pgjp5h7b4wflrenfgzqg2 content esgSubNav
In This List

Natus board approves $30M share repurchase program

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Natus board approves $30M share repurchase program

The Natus Medical Inc. board authorized the repurchase of up to $30 million of the company's common shares.

The Pleasanton, Calif.-based healthcare distributor will use cash on hand, cash generated from operations, as well as existing credit facilities or other financing to fund the transaction.

As of Dec. 31, 2017, the company had cash and cash equivalents of approximately $89 million and availability under an existing line of credit of $70 million.

The share repurchase program is set to expire Feb. 26, 2019.